CFDE Data Portal | Search LINC01214

	Label	Description
	LINC01214 associations Collection (Entity type)	Associations for LINC01214_associations
	LINC01214 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	LINC01214 Gene (Entity type)	ENSG00000243550 - long intergenic non-protein coding RNA 1214
	GSE161800 cisplatin A-549 0 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE143782 calcitriol 3 v 11 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE226115 GSE226116 doxorubicin cardiac endothelial cell 2 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE184892 trehalose fibroblast 6 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE221329 ERK BRAF inhibition thyroid gland 1 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE81796 enzalutamide LNCaP C4-2 0 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS

LINC01214 associations

Associations for LINC01214_associations

LINC01214 associations.tsv

A file from IDG as part of the Harmonizome project

LINC01214

ENSG00000243550 - long intergenic non-protein coding RNA 1214

GSE161800 cisplatin A-549 0 v 2 human up

A Gene Set from LINCS

GSE143782 calcitriol 3 v 11 human up

A Gene Set from LINCS

GSE226115 GSE226116 doxorubicin cardiac endothelial cell 2 v 0 human dn

A Gene Set from LINCS

GSE184892 trehalose fibroblast 6 v 5 human dn

A Gene Set from LINCS

GSE221329 ERK BRAF inhibition thyroid gland 1 v 7 human up

A Gene Set from LINCS

GSE81796 enzalutamide LNCaP C4-2 0 v 2 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.